JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort

Absence of CALR mutation among a cohort of 394 unselected patients with a first episode of unprovoked venous thromboembolism

(2016) Damien Luque Paz et al.   THROMBOSIS AND HAEMOSTASIS

Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis

(2015) Fanny Turon et al.   JOURNAL OF HEPATOLOGY

JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate

(2014) C. Nielsen et al.   HAEMATOLOGICA

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

(2014) E. Lippert et al.   HAEMATOLOGICA

Systematic Review: The Trousseau Syndrome Revisited: Should We Screen Extensively for Cancer in Patients with Venous Thromboembolism?

(2013) Marc Carrier et al.   ANNALS OF INTERNAL MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

(2009) F. Dentali et al.   BLOOD